Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Plugging the leaks in our aging grids could save almost $230 billion in energy costs over the next decade, Bloomberg Opinion ...

After finishing one-two 13 days ago at Pocono Downs, Another C Note and Lafitte both came south and promptly won the two ...

Explore the UFO mysteries J. Allen Hynek uncovered with Project Blue Book and how his findings challenged the Air Force's ...